Neuroendocrine neoplasms (NENs), which are characterized by neuroendocrine
differentiation, can arise in various organs. NENs have been divided into well-differentiated …

Simple Summary Esophageal cancer is the seventh leading cause of cancer-related
mortality worldwide, with a 5-year survival rate of around 20%. Recently, deep learning (DL) …

Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for
their management. The main clinical obstacles are the high rate of patients diagnosed at …

Simple Summary Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a
group of tumors with different clinical manifestations, various localizations in the human …

Background & Aims Despite previously reported treatment strategies for nonfunctioning
small (≤ 20 mm) pancreatic neuroendocrine neoplasms (pNENs), uncertainties persist. We …

Gastroenteropancreatic neuroendocrine neoplasia (GEP-NEN) is a heterogeneous and
complex group of tumors that are often difficult to classify due to their heterogeneity and …

Purpose Liver metastasis is one of the most important factors affecting the prognosis of
patients with neuroendocrine neoplasms (NENs). Transhepatic artery embolization (TAE) is …

Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors that arise from
cells with a neuroendocrine phenotype. These cells secrete specific peptide hormones and …

The management of neuroendocrine tumors (NETs) represents a clinical challenge due to
heterogeneity of their clinical behaviour, molecular biology and response to treatment. Over …

Background: Neuroendocrine neoplasms are a heterogeneous group of tumors that raise
challenges in terms of diagnosis, treatment and monitoring. Despite continuous efforts, no …